Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    1.

    Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulation.

    Simon G, Parker M, Ramiya V, Wasserfall C, Huang Y, Bresson D, Schwartz RF, Campbell-Thompson M, Tenace L, Brusko T, Xue S, Scaria A, Lukason M, Eisenbeis S, Williams J, Clare-Salzler M, Schatz D, Kaplan B, Von Herrath M, Womer K, Atkinson MA.

    Diabetes. 2008 Feb;57(2):405-14. Epub 2007 Nov 26.PMID: 18039815 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice.

    Parker MJ, Xue S, Alexander JJ, Wasserfall CH, Campbell-Thompson ML, Battaglia M, Gregori S, Mathews CE, Song S, Troutt M, Eisenbeis S, Williams J, Schatz DA, Haller MJ, Atkinson MA.

    Diabetes. 2009 Oct;58(10):2277-84. Epub 2009 Jul 23.PMID: 19628781 [PubMed - indexed for MEDLINE]Related articles

    3.

    Rabbit polyclonal mouse antithymocyte globulin administration alters dendritic cell profile and function in NOD mice to suppress diabetogenic responses.

    Huang Y, Parker M, Xia C, Peng R, Wasserfall C, Clarke T, Wu L, Chowdhry T, Campbell-Thompson M, Williams J, Clare-Salzler M, Atkinson MA, Womer KL.

    J Immunol. 2009 Apr 15;182(8):4608-15.PMID: 19342635 [PubMed - indexed for MEDLINE]Related articles

    4.

    Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes.

    Ogawa N, Minamimura K, Kodaka T, Maki T.

    J Autoimmun. 2006 Jun;26(4):225-31. Epub 2006 May 18.PMID: 16713179 [PubMed - indexed for MEDLINE]Related articles

    5.

    Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice.

    Khil LY, Jun HS, Kwon H, Yoo JK, Kim S, Notkins AL, Yoon JW.

    Diabetologia. 2007 Oct;50(10):2147-55. Epub 2007 Aug 4.PMID: 17676307 [PubMed - indexed for MEDLINE]Related articles

    6.

    Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion.

    Goudy KS, Burkhardt BR, Wasserfall C, Song S, Campbell-Thompson ML, Brusko T, Powers MA, Clare-Salzler MJ, Sobel ES, Ellis TM, Flotte TR, Atkinson MA.

    J Immunol. 2003 Sep 1;171(5):2270-8.PMID: 12928371 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.

    Gregori S, Giarratana N, Smiroldo S, Adorini L.

    J Immunol. 2003 Oct 15;171(8):4040-7.PMID: 14530324 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.

    Mukherjee R, Chaturvedi P, Qin HY, Singh B.

    J Autoimmun. 2003 Nov;21(3):221-37.PMID: 14599847 [PubMed - indexed for MEDLINE]Related articles

    9.

    In vivo characterization of rabbit anti-mouse thymocyte globulin: a surrogate for rabbit anti-human thymocyte globulin.

    Ruzek MC, Neff KS, Luong M, Smith KA, Culm-Merdek K, Richards SM, Williams JM, Perricone M, Garman RD.

    Transplantation. 2009 Jul 27;88(2):170-9.PMID: 19623011 [PubMed - indexed for MEDLINE]Related articles

    10.

    CD3 antibody treatment stimulates the functional capability of regulatory T cells.

    Chatenoud L.

    Novartis Found Symp. 2003;252:279-86; discussion 286-90. Review.PMID: 14609225 [PubMed - indexed for MEDLINE]Related articles

    11.

    Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.

    Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD, Sutherland DE, Hering BJ, Guo Z.

    Transplantation. 2009 Jan 27;87(2):198-206.PMID: 19155973 [PubMed - indexed for MEDLINE]Related articles

    12.

    Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.

    Moriyama H, Yokono K, Amano K, Nagata M, Hasegawa Y, Okamoto N, Tsukamoto K, Miki M, Yoneda R, Yagi N, Tominaga Y, Kikutani H, Hioki K, Okumura K, Yagita H, Kasuga M.

    J Immunol. 1996 Oct 15;157(8):3737-43.PMID: 8871677 [PubMed - indexed for MEDLINE]Related articles

    13.

    Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.

    Chosich N, Harrison LC.

    Diabetologia. 1993 Aug;36(8):716-21.PMID: 8405738 [PubMed - indexed for MEDLINE]Related articles

    14.

    Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.

    Emamaullee JA, Davis J, Merani S, Toso C, Elliott JF, Thiesen A, Shapiro AM.

    Diabetes. 2009 Jun;58(6):1302-11. Epub 2009 Mar 16.PMID: 19289457 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells.

    You S, Belghith M, Cobbold S, Alyanakian MA, Gouarin C, Barriot S, Garcia C, Waldmann H, Bach JF, Chatenoud L.

    Diabetes. 2005 May;54(5):1415-22.PMID: 15855328 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.

    Chen C, Lee WH, Yun P, Snow P, Liu CP.

    J Immunol. 2003 Jul 15;171(2):733-44.PMID: 12847240 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.

    Ploix C, Bergerot I, Durand A, Czerkinsky C, Holmgren J, Thivolet C.

    Diabetes. 1999 Nov;48(11):2150-6.PMID: 10535448 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.

    Alard P, Manirarora JN, Parnell SA, Hudkins JL, Clark SL, Kosiewicz MM.

    Diabetes. 2006 Jul;55(7):2098-105.PMID: 16804081 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.

    Tritt M, Sgouroudis E, d'Hennezel E, Albanese A, Piccirillo CA.

    Diabetes. 2008 Jan;57(1):113-23. Epub 2007 Oct 10.PMID: 17928397 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice.

    Qin HY, Sadelain MW, Hitchon C, Lauzon J, Singh B.

    J Immunol. 1993 Mar 1;150(5):2072-80.PMID: 8436836 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data